EP3626309
LXRBETA AGONIST FOR THE TREATMENT OF CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.8.2013EP published:
8.3.2023EP application number:
19189895.6
EPO information:
European Patent Register
Max expiry date:
12.8.2033
Title in English:
LXRBETA AGONIST FOR THE TREATMENT OF CANCERLanguage of the patent:
English
Timeline
Today
13.8.2013EP application
8.3.2023EP Publication
Owner
Name:
The Rockefeller UniversityAddress:
1230 York Avenue, New York, NY 10065, US
Inventor
Name:
TAVAZOIE, SohailAddress:
New York, NY 10065, US
Name:
PENCHEVA, Nora, G.Address:
New York, NY 10065, US
Priority
Number:
201261682339 PDate:
13.8.2012Country:
US
Number:
201361784057 PDate:
14.3.2013Country:
US
Classification
Categories:
A61P 35/04, C12N 15/113, A61K 31/136, A61K 31/4155, A61K 31/416